Acuity Pharmaceuticals logo — Advancing Ophthalmic Health with Pioneering Solutions

Acuity Pharmaceuticals

Advancing Ophthalmic Health with Pioneering Solutions

Founded 2002 Series B Total: $19.00M Health Care, Pharmaceutical

General Information

Company Name Acuity Pharmaceuticals
Founded Year 2002
Industries Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when Acuity Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Acuity Pharmaceuticals

Acuity Pharmaceuticals is a Philadelphia-based health care and pharmaceutical company established in 2007. Specializing in the treatment and prevention of eye diseases, the company has developed pioneering solutions for age-related macular degeneration and diabetic retinopathy. One of its key products, Cand5, is a clinical compound that effectively inhibits vascular endothelial growth factor. Acuity Pharmaceuticals received a significant boost when it secured a $15.00M Series B investment in October 2004 from prominent investors including BioAdvance, Ben Franklin Technology Partners of Southeastern Pennsylvania, Psilos Group, Johnson & Johnson Development Corporation, and Diamond Capital. The company's commitment to advancing ophthalmic health is evident through its acquisition by OPKO Health in June 2011. With a strong portfolio of innovative treatments and a solid backing from reputable investors, Acuity Pharmaceuticals is well-positioned to continue making impactful strides in the field of ophthalmic health.

Taxonomy: ophthalmic health, eye diseases, ophthalmic pharmaceuticals, age-related macular degeneration, diabetic retinopathy, Cand5, vascular endothelial growth factor, Philadelphia, Pennsylvania, pharmaceutical company, OPKO Health, acquisition, treatment development, innovation, clinical compounds

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 5
Investor Investor Investor Investor Investor
07 Oct 2004
Venture Round •••••• 1
Investor
01 Jun 2004
Series A •••••• - 15 Jan 2004
Venture Round •••••• - 19 Jun 2003

Acuity Pharmaceuticals Alternatives & Competitors

Acuity Pharmaceuticals vs
Acuity Eye Group
Acuity Eye Group United States

Our Vision is Your Vision

302 employees
Fashion, Health Care
Acuity Pharmaceuticals vs
EarlySight
EarlySight Switzerland

See the invisible

Seed
10 employees
Health Care
Acuity Pharmaceuticals vs

Odin Pharmaceuticals is a rapidly growing sterile pharmaceutical company

28 employees
Pharmaceutical

FAQ About Acuity Pharmaceuticals

Advancing Ophthalmic Health with Pioneering Solutions
Acuity Pharmaceuticals was founded in 2002.
Acuity Pharmaceuticals operates in the following industries: Health Care, Pharmaceutical.
Acuity Pharmaceuticals has completed 4 funding rounds, raising a total of $19.00M. The latest funding stage is Series B.
Top alternatives and competitors to Acuity Pharmaceuticals include Acuity Eye Group, EarlySight, Odin Pharmaceuticals, LLC, Sigma Pharmaceuticals, LLC, Acuity Capital. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acuity Pharmaceuticals and Acuity Eye Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Acuity Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes